Metipranolol attenuates lipid peroxidation in rat brain: A comparative study with other antiglaucoma drugs

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 10, 2003, Pages 827-833

  Melena, José ^a,b   Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; ANTIOXIDANT; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DEACETYLMETIPRANOLOL; DORZOLAMIDE; DRUG METABOLITE; FREE RADICAL; IRON; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; NITROPRUSSIDE SODIUM; PILOCARPINE; PINDOLOL; PROPRANOLOL; PROSTAGLANDIN DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TIMOLOL; TRAVOPROST; TROLOX C; UNCLASSIFIED DRUG; UNOPROSTONE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG STRUCTURE; EYE DISEASE; IC 50; LIPID PEROXIDATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ASCORBIC ACID; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FERROUS COMPOUNDS; FREE RADICAL SCAVENGERS; LIPID PEROXIDATION; METIPRANOLOL; NITROPRUSSIDE; OPHTHALMIC SOLUTIONS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0242521294     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0726-5     Document Type: Article

References (41)

1. Abshagen U, Betzien G, Kaufmann B, Endele G (1982) Pharmacokinetics of metipranolol in normal man. Eur J Clin Pharmacol 21:293-301
2. Acheampong AA, Shackleton M, John B, Burke J, Wheeler L, Tang-Liu D (2002) Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. Drug Metab Dispos 30:421-429
3. Agarwal N, Martin E, Krishnamoorthy RR, Landers R, Wen R, Krueger S, Kapin MA, Collier RJ (2002) Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy. Exp Eye Res 74:445-453
4. Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B (1991) Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically significant process? Biochem Pharmacol 42:735-743
5. Baptiste DC, Hartwick AT, Jollimore CA, Baldridge WH, Chauhan BC, Tremblay F, Kelly ME (2002) Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina. Invest Ophthalmol Vis Sci 43:2666-2676
6. Bonne C, Muller A, Villain M (1998) Free radicals in retinal ischemia. Gen Pharmacol 30:275-280
7. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ (2002) Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 50:341-351
8. Chakraborty H, Ray SN, Chakrabarti S (2001) Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate. Neurochem Int 39:311-317
9. 2-adrenoceptors and not by an action on imidazoline receptors. Brain Res 904:126-136
10. + channels: comparison with other β-adrenoceptor antagonists. Br J Pharmacol 130:759-766
11. Dahlin DC, Curtis MA, DeSantis L, Struble CB (2000) Distribution of betaxolol to posterior ocular tissues of the cynomolgus monkey following a 30-day BID topical ocular regimen of Betoptic S. Invest Ophthalmol Vis Sci 41:S509
12. De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C (2000) Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res 20:85-94
13. Gao H, Qiao X, Cantor LB, WuDunn D (2002) Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol 120:797-803
14. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E (1998) Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med 25:369-372
15. Gvozdják J, Gvozdjáková A, Kucharská J, Bada V (1989) Cardioprotective effect of metipranolol on ischemic heart muscle. Cardiology 76:206-210
16. Huang YC, Wu BN, Yeh JL, Chen SJ, Liang JC, Lo YC, Chen IJ (2001) A new aspect of view in synthesizing new type β-adrenoceptor blockers with ancillary antioxidant activities. Bioorg Med Chem 9:1739-1746
17. Kessler C, Bleckmann H, Kleintges G (1991) Influence of the concentration of metipranolol eye drops on the drug concentration in human aqueous humour. Graefes Arch Clin Exp Ophthalmol 229:487-491
18. Lafuente MP, Villegas-Pérez MP, Mayor S, Aguilera ME, Miralles de Imperial J, Vidal-Sanz M (2002) Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study. Exp Eye Res 74:181-189
19. Melena J, Stanton D, Osborne NN (2001) Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels. Graefe's Arch Clin Exp Ophthalmol 239:522-530
20. 2+ channels. Eur J Pharmacol 378:317-322
21. Miura T, Muraoka S, Fujimoto Y (1999) Inhibition of lipid peroxidation by pindolol. Pharmacol Toxicol 84:130-134
22. Miura T, Muraoka S, Ogiso T (1995) Protective effects of β-blockers against 2,2′-azobis(2-amidinopropane)-dihydrochloride-induced damage. Chem Biol Interact 97:25-35
23. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
24. Osborne NN, Chidlow G, Wood JPM, Schmidt KG, Casson R, Melena J (2001) Expectations in the treatment of retinal diseases: neuroprotection. Curr Eye Res 22:321-332
25. Osborne NN, DeSantis L, Bae JH, Ugarte M, Wood JPM, Nash MS, Chidlow G (1999) Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp Eye Res 69:331-342
26. Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JPM, Nash MS (1999) Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 43 Suppl 1:102-128
27. Rao NA, Wu GS (2000) Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res 19:41-68
28. Rauhala P, Khaldi A, Mohanakumar KP, Chiueh CC (1998) Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radic Biol Med 24:1065-1073
29. Shimmura S, Masumizu T, Nakai Y, Urayama K, Shimazaki J, Bissen-Miyajima H, Kohno M, Tsubota K (1999) Excimer laser-induced hydroxyl radical formation and keratocyte death in vitro. Invest Ophthalmol Vis Sci 40:1245-1249
30. Spector A (1995) Oxidative stress-induced cataract: mechanism of action. FASEB J 9:1173-1182
31. Stagni G, Davis PJ, Ludden TM (1991) Human pharmacokinetics of betaxolol enantiomers. J Pharm Sci 80:321-324
32. Sugawara H, Tobise K, Onodera S (1994) Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem Pharmacol 47:887-892
33. Sugrue MF (1997) New approaches to antiglaucoma therapy. J Med Chem 40:2793-2809
34. Tan AY, LeVatte TL, Archibald ML, Tremblay F, Kelly ME, Chauhan BC (2002) Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing. J Glaucoma 11:134-142
35. Walter KA, Gilbert DD (2001) The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients. Ophthalmology 108:1434-1438
36. Weglicki WB, Mak IT, Simic MG (1990) Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 22:1199-1208
37. Weinreb RN, Levin LA (1999) Is neuroprotection a viable therapy for glaucoma? Arch Ophthalmol 117:1540-1544
38. Wood JPM, DeSantis L, Chao HM, Osborne NN (2001) Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA. Exp Eye Res 72:79-86
39. Wood JPM, Schmidt KG, Melena J, Chidlow G, Osborne NN (2003) The β-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 76:505-516
40. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G (1992) Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 263:92-98
41. Zhou L, Li Y, Yue BY (1999) Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J Cell Physiol 180:182-189